← Eichor
Condition: Natriuretic Peptides Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Natriuretic Peptides

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and ech
NA · 7 location(s) · NHS Greater Glasgow and Clyde · NCT05919342CANF-Comb-II PET-MR in Atherosclerosis Multisite
Phase N/A · 2 location(s) · Washington University School of Medicine · NCT05838547Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT06849752BNP in Pediatric Metabolic Syndrome
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07181733CARBON: UAB Cardiovascular Research Biobank
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT05067231Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
Phase N/A · 2 location(s) · IRCCS Ospedale San Raffaele · NCT07013344Right Ventricular Function Changes After CIED Implantation: The RIGHT-CIED Study
Phase N/A · 1 location(s) · Istanbul University - Cerrahpasa · NCT07272395Measurement Of NT-proBNP to Predict Outcomes in Surgery
Phase N/A · 1 location(s) · Norfolk and Norwich University Hospitals NHS Foundation Trus · NCT04014647Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Unde
Phase 4 · 1 location(s) · Vitor Emer Egypto Rosa · NCT07099859GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
NA · 1 location(s) · University of Alabama at Birmingham · NCT05216042A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treat
Phase 2 · 36 location(s) · BioMarin Pharmaceutical · NCT06668805NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT04055428Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proB
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05797649Point-of-care Ultrasound Abnormalities in Eclampsia
NA · 1 location(s) · University of Cape Town · NCT05678062Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure
NA · 3 location(s) · Cardiology Research UBC · NCT05859048Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
Phase 2/Phase 3 · 19 location(s) · BioMarin Pharmaceutical · NCT07441876STUDY OF THE DOUBLE POLYMORPHISM (THR 555ILE) AND (GLU568PRO) OF THE CORIN GENE AS A RISK FACTOR FOR ARTERIAL HYPERTENSI
NA · 2 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT07330804PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
Phase 2/Phase 3 · 1 location(s) · University of Alabama at Birmingham · NCT04971720
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.